At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 95 enrolled
Drug / intervention
Terbutaline sulphate +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Double-dummy, Multi-site, Phase III, Single Dose, 4-way Cross-over Pharmacodynamic Study Evaluating the Efficacy of Bricanyl Turbuhaler M3 Compared to Bricanyl Turbuhaler M2 by Studying the Protective Effect on Methacholine Induced Bronchoconstriction in Patients With Stable, Mild to Moderate Asthma
In Brief
A Phase 3 clinical trial evaluating Terbutaline sulphate and Placebo for terbutaline sulphate for Asthma. Completed, enrolled 95 participants across 4 sites in 3 countries.
Detailed Summary
A randomised, double-blind, double-dummy, multi-site, phase III, single dose, 4-way cross-over pharmacodynamic study evaluating the efficacy of Bricanyl Turbuhaler M3 compared to Bricanyl Turbuhaler M2 by studying the protective effect on methacholine induced bronchoconstriction in patients with stable, mild to moderate asthma
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesCanada, Netherlands, Sweden
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartMar 2015
Primary CompletionNov 2015
TodayJul 2026
First PostedDec 23, 2014
Enrollment StartMar 1, 2015
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.5 years ago
Interventions
Terbutaline sulphatedrug
Bricanyl Turbuhaler M2
Terbutaline sulphatedrug
Bricanyl Turbuhaler M3
Placebo for terbutaline sulphatedrug
Placebo Turbuhaler M2
Placebo for terbutaline sulphatedrug
Placebo Turbuhaler M3